References
- Gupta AK, Gover MD, Nouri K, Taylor S. The treatment of melasma: A review of clinical trials. J Am Acad Dermatol. 2006;55:1048–65.
- Prignano F, Ortanne JP, Buggiani G, Lotti T. Therapeutic approaches in melasma. Dermatol Clin. 2007;25:337–42.
- Grimes PE. Melasma: Etiologic and therapeutic consideration. Arch Dermatol. 1995;131:1453–7.
- Kang WH, Yoon KH, Lee ES, Kim J, Lee KB, Yim H, . Melasma: Histopathological characteristics in 56 Korean patients. Br J Dermatol. 2002;146:228–37.
- Cestari TF, Hassun K, Sittart A, Viegas MdL. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. J Cosmet Dermatol. 2007;6:36–9.
- Haddad AL, Matos LF, Bruenstein F, Ferreira LM, Silva A, Costa D Jr. A clinical, prospective, randomized, double-blind trial comparing skin whitening complex with hydroquinone vs. placebo in treatment of melasma. Int J Dermatol. 2003;42:153–6.
- Kligman AM, Willis I. A new formula for depigmentating human skin. Arch Dermatol. 1975;111:40–8.
- Taylor SC, Torok H, Jones T, Lowe N, Rich P, Tschen E, . Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. Cutis. 2003;72:67–72.
- Maeda K, Fukuda M. Arbutin: Mechanism of its depigmenting action in human melanocyte culture. J Pharmacol Exp Ther. 1996;276:765–9.
- Chakarborty AK, Funasaka Y, Komoto M, Ichihasshi M. Effect of arbutin on melanogenic proteins in human melanocytes. Pigment Cell Res. 1998;11:206–12.
- Sugimoto K, Nishimura T, Nomura K, Sugimoto K, Kuriki T. Syntheses of arbutin alpha glycosides and a comparison of their inhibitory effects with those of alpha arbutin and arbutin on human tyrosinase. Chem Pharm Bull (Tokyo). 2003;51:798–801.
- Kopora D, Hohenleutner U. Ruby laser treatment of melasma and post inflammatory hyperpigmentation. Dermatol Surg. 1995;21:990–5.
- Lipper GM, Anderson RR. Lasers in dermatology. Freedberg IM, Eisen AZ, Wolf K, . Fitzpatrick dermatology in general medicine. New York: McGraw Hill; 2003. 2508–9.
- Rusciani A, Motta A, Rusciani L, Alfano. Q-switched alexandrite laser-assisted treatment of melasma, 2 years follow up monitoring. J Drugs Dermatol. 2005;6:770–4.
- Palumbo A, d'Ischia M, Misuraca G, Procta G. Mechanism of inhibition of melanogenesis by hydroquinone. Biochem Biophysic Acta. 1991;1073:85–90.
- Lim JT. Treatment of melasma using kojic acid in a gel containing hydroquinone and glycolic acid. Dermatol Surg. 1999;25:282–4.
- Huerta Brogeras M, Sanchez Vira M. Exogenous ochronosis. J Drugs Dermatol. 2006;5:80–1.
- Balina LM, Graupe K. The treatment of melasma: 20% azaleic acid versus 4% hydroquinone cream. Int J Dermatol. 1991;30:893–5.
- Kunachak S, Leedaudomlipi P, Wongwaisayawan S. Dermabrasion: A curative treatment for melasma. Aesthetic Plast Surg. 2001;25:114–17.
- Nouri K, Bowes L, Chartier T, Romangosa R, Spencer J. Combination treatment of melasma with pulsed C02 laser followed by Q-switched alexandrite laser: A pilot study. Dermatol Surg. 1999;25:494–7.
- Angsuwarangsee S, Polnikorn N. Combination ultrapulse C02 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma. Dermatol Surg. 2003;29:59–64.
- Malaloto RM, Alster T. Erbium-YAG laser resurfacing for refractory melasma. Dermatol Surg. 1999;25:121–3.
- Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: A pilot-study. Dermatol Surg. 2005;31:1645–50.
- Naito SK. Fractional photothermolysis treatment for resistant melasma in Chinese female. J Cosmet Laser Ther. 2007;9:161–3.
- Hantash BM, Bedi VP, Sudireddy V, Struck SK, Herron GS, Chan KF. Laser-induced transepidermal elimination of dermal content by fractional thermolysis. J Biomed Opt. 2006;11:04115.
- Tannous ZS, Astner S. Utilizing fractional resurfacing in therapy resistant melasma. J Cosmet Laser Ther. 2005;7:39–43.